New drug aims to prevent heart damage after surgery
NCT ID NCT07028593
Summary
This study is testing if a new anesthetic drug called Ciprofol is better than the standard drug, propofol, at preventing heart injury in patients having lung surgery. It will involve over 1,000 adults aged 45-80 undergoing common lung procedures. The main goal is to see if Ciprofol, which may cause fewer blood pressure drops, leads to fewer cases of post-surgery heart damage.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MYOCARDIAL INJURY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Tongji hospital
RECRUITINGWuhan, China
Contact
Contact
Conditions
Explore the condition pages connected to this study.